Zai Lab (ZLAB) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Zai Lab (ZLAB) is Neutral.

The composite score behind that read is +0.13, weighing +0.36 of bullish evidence against -0.18 bearish.

Zai Lab last closed at $24.99, +0.73% on the session.

Against the IVW growth benchmark the position is -0.07% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

5 graded predictions for ZLAB so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Zai Lab in the 24th percentile on return on equity, where 100 is best.

Zai Lab is classified under Health Care / Biotechnology, with a market capitalisation of $2.82B.

StockMap tracks Zai Lab as the 72nd largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Zai Lab ranks 41st of 381 in the group, against a group median of -0.08.